{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:54:20Z","timestamp":1791021260513,"version":"4.1.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jconrel.2024.10.011","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:47:32Z","timestamp":1729075652000},"page":"266-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The journey of nanoparticles in the abdominal cavity: Exploring their in vivo fate and impact factors"],"prefix":"10.1016","volume":"376","author":[{"given":"Shu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.10.011_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0015","first-page":"309","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial, the lancet","volume":"17","author":"Fujitani","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","article-title":"Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer","volume":"87","author":"Maehara","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0025","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0030","first-page":"16","article-title":"Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and Cancer","volume":"5","author":"Testa","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00384-023-04340-w","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastasis of colorectal cancer: long-term follow-up results at a single institution in Korea","volume":"38","author":"Lee","year":"2023","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14701\/ahbps.21-071","article-title":"Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma","volume":"26","author":"Choi","year":"2022","journal-title":"Ann. Hepato-Biliary-Pancreatic Surgery"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030570","article-title":"Review of regional therapies for gastric Cancer with peritoneal metastases","volume":"14","author":"Sun","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/annonc\/mdp260","article-title":"Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis","volume":"21","author":"Ishigami","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jjco\/hyq187","article-title":"A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial)","volume":"41","author":"Kodera","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12029-014-9603-1","article-title":"Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis","volume":"45","author":"Takahara","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0960-7404(93)90019-U","article-title":"Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposide","volume":"2","author":"Lindn\u00e9r","year":"1993","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0070","series-title":"Liver Cancer","first-page":"225","article-title":"Intraperitoneal chemotherapy: A possible role in the treatment of hepatic metastases","author":"Speyer","year":"1985"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0075","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00449-020-02330-8","article-title":"Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure","volume":"43","author":"Khan","year":"2020","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Translat. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tice.2016.11.004","article-title":"The histophysiology and pathophysiology of the peritoneum","volume":"49","author":"van Baal","year":"2017","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00276-008-0456-9","article-title":"Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas","volume":"31","author":"Albanese","year":"2009","journal-title":"Surg. Radiol. Anat."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2018.09.007","article-title":"Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature","volume":"92","author":"Kastelein","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118456","article-title":"Therapeutic delivery to the peritoneal lymphatics: current understanding, potential treatment benefits and future prospects","volume":"567","author":"Sarfarazi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0120","article-title":"Comparison of diagnostic efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET\/CT for staging and restaging of gastric Cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0125","article-title":"The clinical significance of mesenteric lymphocytes in human colorectal Cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.sempedsurg.2014.06.002","article-title":"Anatomy and physiology of the peritoneum","volume":"23","author":"Blackburn","year":"2014","journal-title":"Semin. Pediatr. Surg."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0940-9602(99)80040-5","article-title":"Scanning and transmission electron microscopic study of visceral and parietal peritoneal regions in the rat","volume":"181","author":"Michailova","year":"1999","journal-title":"Ann. Anatomy - Anat. Anz."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/path.1711450204","article-title":"Mesothelial healing: morphological and kinetic investigations","volume":"145","author":"Whitaker","year":"1985","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0145","first-page":"90","article-title":"Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity","volume":"26","author":"Shimotsuma","year":"1993","journal-title":"Lymphology"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/aja.1001650305","article-title":"Structure, blood supply, and lymphatic vessels of the sheep\u2019s visceral pleura","volume":"165","author":"Albertine","year":"1982","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000183024","article-title":"Ultrastructure of normal rabbit mesentery","volume":"34","author":"Gotloib","year":"1983","journal-title":"Nephron"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365521.1970.12096563","article-title":"Transperitoneal exchange. II. Peritoneal blood flow estimated by hydrogen gas clearance","volume":"5","author":"Aune","year":"1970","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0165","series-title":"Nolph and Gokal\u2019s Textbook of Peritoneal Dialysis","first-page":"51","article-title":"The peritoneal microcirculation in peritoneal Dialysis","author":"De Vriese","year":"2009"},{"issue":"Suppl. 4","key":"10.1016\/j.jconrel.2024.10.011_bb0170","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080002004S03","article-title":"Pathophysiology of peritoneal membrane failure","volume":"20","author":"Krediet","year":"2000","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","article-title":"Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion","volume":"17","author":"Ceelen","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0180","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/2101123a0","article-title":"Peritoneal fluid volume and the oestrus cycle in mice","volume":"210","author":"Hartveit","year":"1966","journal-title":"Nature"},{"issue":"1963","key":"10.1016\/j.jconrel.2024.10.011_bb0185","first-page":"483","article-title":"Peritoneal fluid pH after perforation of peptic ulcers: the myth of \u201cacid-peritonitis\u201d","volume":"87","author":"Howard","year":"1960","journal-title":"Arch. Surgery (Chicago, Ill)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/rep.0.1230217","article-title":"Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis","volume":"123","author":"Gazvani","year":"2002","journal-title":"Reproduction (Cambridge, England)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0200","first-page":"1138","article-title":"Protein electrophoretic patterns of serum and peritoneal fluid in normal, tumor-bearing, and immune mice","volume":"28","author":"Brenneman","year":"1968","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.4942","article-title":"The peritoneum: healing, immunity, and diseases","volume":"243","author":"Capobianco","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0210","article-title":"Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis, Cell reports","volume":"3","author":"Hendrikson","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0215","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/ijms19051386","article-title":"Polysaccharides extracted from Rhizoma Pleionis have antitumor properties in vitro and in an H22 mouse hepatoma ascites model in vivo","volume":"19","author":"Fang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0220","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jcmm.12575","article-title":"The impact of inflammatory cells in malignant ascites on small intestinal ICCs\u2019 morphology and function","volume":"19","author":"Li","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0225","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-11-210","article-title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","volume":"11","author":"Lane","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0230","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0235","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1007\/s13277-015-4198-0","article-title":"The clinical significance of vascular endothelial growth factor in malignant ascites","volume":"37","author":"Zhan","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0240","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2147\/OTT.S51916","article-title":"VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody","volume":"6","author":"Fushida","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clinbiochem.2018.04.003","article-title":"Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers","volume":"56","author":"Jin","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0250","first-page":"360","article-title":"Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation","volume":"55","author":"Nagy","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4613-1247-5_4","article-title":"Peritoneal-plasma barrier","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms20010217","article-title":"Evaluation of the biological behavior of a gold Nanocore-encapsulated human serum albumin nanoparticle (Au@HSANP) in a CT-26 tumor\/ascites mouse model after intravenous\/intraperitoneal administration","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"Bree","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0270","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jconrel.2022.10.032","article-title":"Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: beyond EPR effect","volume":"352","author":"Yamamoto","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.10.011_bb0275","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0280","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1101\/gad.282400.116","article-title":"Mechanotransduction activates canonical Wnt\/\u03b2-catenin signaling to promote lymphatic vascular patterning and the development of lymphatic and lymphovenous valves","volume":"30","author":"Cha","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0285","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0290","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI71610","article-title":"Lymphatic transport of high-density lipoproteins and chylomicrons","volume":"124","author":"Randolph","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/039139880703000610","article-title":"Possible role of milky spots in mesothelial transplantation","volume":"30","author":"Sacchi","year":"2007","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/icb.1950.15","article-title":"The lymphatic drainage of plasma from the peritoneal cavity of the cat","volume":"28","author":"Courtice","year":"1950","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0305","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","author":"Tsai","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0940-9602(01)80168-0","article-title":"Postinflammatory changes of the diaphragmatic stomata","volume":"183","author":"Michailova","year":"2001","journal-title":"Ann. Anat."},{"issue":"1991","key":"10.1016\/j.jconrel.2024.10.011_bb0315","first-page":"1544","article-title":"Distribution of diaphragmatic lymphatic stomata","volume":"70","author":"Negrini","year":"1985","journal-title":"J. Appl. Physiol. (Bethesda Md.)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000147094","article-title":"Study on the ultrastructure of the peritoneal stomata in humans","volume":"141","author":"Li","year":"1991","journal-title":"Acta Anat."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0325","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/720858","article-title":"Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent","volume":"2013","author":"De Smet","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.887402","article-title":"Targeting lymphatics for nanoparticle drug delivery","volume":"13","author":"McCright","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2006.10.006","article-title":"Anatomy of the lymphatics","volume":"16","author":"Skandalakis","year":"2007","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0340","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/01926230600867727","article-title":"Normal structure, function, and histology of lymph nodes","volume":"34","author":"Willard-Mack","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0345","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-319-27532-1_8","article-title":"Cervical: lymphadenopathy","author":"Sakr","year":"2016","journal-title":"Head Neck Endocrine Surgery"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0355","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00686048","article-title":"Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment","volume":"25","author":"Los","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcdb.2009.10.010","article-title":"Cancer associated fibroblasts in cancer pathogenesis","volume":"21","author":"Franco","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188895","article-title":"Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics","volume":"1878","author":"Saifi","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0370","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.1213353109","article-title":"Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors","volume":"109","author":"Stylianopoulos","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904337","article-title":"Recent advances in Nanostrategies capable of overcoming biological barriers for tumor management","volume":"32","author":"Huo","year":"2020","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0380","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0385","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","article-title":"The role of mechanical forces in tumor growth and therapy","volume":"16","author":"Jain","year":"2014","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejpb.2020.04.009","article-title":"Potential drug delivery nanosystems for improving tumor penetration","volume":"151","author":"Peng","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0395","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-5793(03)00273-4","article-title":"Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration","volume":"540","author":"Moghimi","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0400","first-page":"241","article-title":"A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents","volume":"1","author":"Hagiwara","year":"1987","journal-title":"In vivo (Athens, Greece)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0405","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/fon.10.100","article-title":"Intraperitoneal therapy for peritoneal cancer","volume":"6","author":"Lu","year":"2010","journal-title":"Future Oncol. (London, England)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0410","first-page":"H26","article-title":"Peritoneal absorption of macromolecules studied by quantitative autoradiography","volume":"248","author":"Flessner","year":"1985","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0415","first-page":"122","article-title":"Absorption of fluid and solutes from the peritoneal cavity","volume":"35","author":"Mactier","year":"1989","journal-title":"Theoretic Therapeutic Implications Appl, ASAIO Trans."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0420","first-page":"1700","article-title":"The lymphatic pathways from the peritoneal cavity: a lymphangiographic study in the rat","volume":"24","author":"Olin","year":"1964","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0425","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ar.1091010308","article-title":"The passage of particulate matter from the peritoneal cavity into the lymph vessels of the diaphragm","volume":"101","author":"Simer","year":"1948","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/lrb.2013.0044","article-title":"Functional anatomy of the mediastinal lymph nodes in rats","volume":"12","author":"Pasierbek","year":"2014","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0435","first-page":"1","article-title":"Characterization of adjuvant induced rat lymphangiomas as a model to study the lymph drainage from abdominal cavity","volume":"27","author":"Ezaki","year":"2004","journal-title":"Japanese J. Lymphol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0440","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1258\/002367792780740549","article-title":"Lymphatic drainage of Listeria inonocytogenes and Indian ink inoculated in the peritoneal cavity of the mouse","volume":"26","author":"Marco","year":"1992","journal-title":"Lab. Anim."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0445","first-page":"F353","article-title":"Lymphatic drainage of the peritoneal cavity in sheep","volume":"260","author":"Abernethy","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0450","first-page":"453","article-title":"Lymphatic drainage from the peritoneal cavity in the dog","volume":"19","author":"Higgins","year":"1929","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0455","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1292\/jvms.68.1143","article-title":"The time course of lymph drainage from the peritoneal cavity in beagle dogs","volume":"68","author":"Shibata","year":"2006","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0460","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1021\/acs.molpharmaceut.9b00855","article-title":"Lymphatic uptake of liposomes after intraperitoneal administration primarily occurs via the diaphragmatic lymphatics and is dependent on liposome surface properties","volume":"16","author":"Lee","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0465","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1439-0264.2006.00742.x","article-title":"The time course of lymphatic routes emanating from the peritoneal cavity in rats","volume":"36","author":"Shibata","year":"2007","journal-title":"Anat. Histol. Embryol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0470","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ki.1987.188","article-title":"Role of peritoneal cavity lymphatic absorption in peritoneal dialysis","volume":"32","author":"Mactier","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioactmat.2022.10.004","article-title":"Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer","volume":"23","author":"Chen","year":"2023","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0480","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jconrel.2023.07.010","article-title":"Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy","volume":"360","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0485","doi-asserted-by":"crossref","first-page":"49022","DOI":"10.1021\/acsami.3c11274","article-title":"CO2-driven nebulization of pH-sensitive supramolecular polymers for intraperitoneal hydrogel formation and the treatment of peritoneal metastasis","volume":"15","author":"Braet","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0490","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.apsb.2019.06.001","article-title":"Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma","volume":"9","author":"Zhao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0495","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jconrel.2011.12.001","article-title":"Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors","volume":"158","author":"Bajaj","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121828","article-title":"Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration","volume":"622","author":"Teja Surikutchi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0505","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1021\/acs.molpharmaceut.1c00514","article-title":"Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a hybrid system containing an Alginic acid-based Nanogel and an in situ cross-linkable hydrogel for peritoneal dissemination of ovarian Cancer","volume":"18","author":"Yamaguchi","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0510","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1073\/pnas.1523141113","article-title":"Improved i.p. drug delivery with bioadhesive nanoparticles","volume":"113","author":"Deng","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0515","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/pharmaceutics13101696","article-title":"Liposomal Resiquimod for enhanced immunotherapy of peritoneal metastases of colorectal Cancer","volume":"13","author":"Pauli","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0520","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2021.12.004","article-title":"I.P.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors","volume":"341","author":"Ando-Matsuoka","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.022","article-title":"Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants","volume":"305","author":"Padmakumar","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0530","first-page":"274","article-title":"Long-term drug delivery using implantable electrospun woven polymeric nanotextiles, nanomedicine: nanotechnology","volume":"15","author":"Padmakumar","year":"2019","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0535","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.molpharmaceut.8b00836","article-title":"3D printing of Poloxamer 407 Nanogel discs and their applications in adjuvant ovarian Cancer therapy","volume":"16","author":"Cho","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0540","doi-asserted-by":"crossref","first-page":"237","DOI":"10.20892\/j.issn.2095-3941.2019.0169","article-title":"The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0545","article-title":"Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models","volume":"48","author":"Hyldbakk","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121534","article-title":"Ultra-high drug loading improves nanoparticle efficacy against peritoneal mesothelioma","volume":"285","author":"Sabatelle","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0555","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.7150\/thno.41622","article-title":"Cartilage repair mediated by thermosensitive photocrosslinkable TGF\u03b21-loaded GM-HPCH via immunomodulating macrophages, recruiting MSCs and promoting chondrogenesis","volume":"10","author":"Ji","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0560","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119785","article-title":"Dual-targeted enzyme-sensitive hyaluronic acid nanogels loading paclitaxel for the therapy of breast cancer","volume":"294","author":"Gao","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0570","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.3390\/ijms23042370","article-title":"Bioadhesive nanoparticles for local drug delivery","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0575","first-page":"413","article-title":"Metronomics: towards personalized chemotherapy?, nature reviews","volume":"11","author":"Andr\u00e9","year":"2014","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.01.152","article-title":"Biological effects of formation of protein corona onto nanoparticles","volume":"175","author":"Mishra","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0585","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jcis.2021.08.148","article-title":"Zhao, influence of nanoparticle mechanical property on protein corona formation","volume":"606","author":"Tengjisi","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0590","doi-asserted-by":"crossref","first-page":"48284","DOI":"10.1021\/acsami.0c12341","article-title":"Protein nanoparticle charge and hydrophobicity govern protein Corona and macrophage uptake","volume":"12","author":"Pustulka","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0595","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0600","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1038\/s41467-019-12470-5","article-title":"Tailoring the component of protein corona via simple chemistry","volume":"10","author":"Lu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114356","article-title":"The effects of protein corona on in vivo fate of nanocarriers","volume":"186","author":"Xiao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0610","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.actbio.2014.03.012","article-title":"Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy","volume":"10","author":"Dakwar","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0615","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41565-021-00924-1","article-title":"Environmental dimensions of the protein corona","volume":"16","author":"Wheeler","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0620","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1021\/la403896h","article-title":"pH-dependent interaction and resultant structures of silica nanoparticles and lysozyme protein","volume":"30","author":"Kumar","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0625","doi-asserted-by":"crossref","first-page":"25482","DOI":"10.1021\/acs.jpcc.5b06266","article-title":"Protein identity and environmental parameters determine the final physicochemical properties of protein-coated metal nanoparticles","volume":"119","author":"Dewald","year":"2015","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0630","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jcis.2017.07.011","article-title":"Hemoglobin bioconjugates with surface-protected gold nanoparticles in aqueous media: the stability depends on solution pH and protein properties","volume":"505","author":"del Ca\u00f1o","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0635","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jconrel.2023.08.017","article-title":"Surgical management of peritoneal metastasis: opportunities for pharmaceutical research","volume":"361","author":"Wientjes","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0640","first-page":"143","article-title":"Types of acute phase reactants and their importance in vaccination","volume":"12","author":"Khalil","year":"2020","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0645","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1021\/jz401874u","article-title":"Controlling the fate of protein Corona by tuning surface properties of nanoparticles","volume":"4","author":"Khan","year":"2013","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0655","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0660","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: a new approach for nanomedicine design","volume":"12","author":"Nguyen","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0665","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biomaterials.2018.03.051","article-title":"Programmed \u2018triple-mode\u2019 anti-tumor therapy: improving peritoneal retention, tumor penetration and activatable drug release properties for effective inhibition of peritoneal carcinomatosis","volume":"169","author":"Cherukula","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0670","doi-asserted-by":"crossref","first-page":"24322","DOI":"10.1021\/acsami.5b08805","article-title":"Disregarded effect of biological fluids in siRNA delivery: human ascites fluid severely restricts cellular uptake of nanoparticles","volume":"7","author":"Dakwar","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0675","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3835(92)90186-Y","article-title":"Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer","volume":"62","author":"Sheid","year":"1992","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0685","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/cas.13777","article-title":"Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer","volume":"109","author":"Nakano","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0690","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20182024","article-title":"Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity","volume":"216","author":"Zhang","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0695","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.biomaterials.2013.01.001","article-title":"In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0928-0987(94)00075-B","article-title":"Recognition of charged liposomes by rat peritoneal and splenic macrophages: effects of fibronectin on the uptake of charged liposomes","volume":"3","author":"Aramaki","year":"1995","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0705","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2010.08.026","article-title":"Peritoneal retention of liposomes: effects of lipid composition, PEG coating and liposome charge","volume":"148","author":"Dadashzadeh","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0710","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.7150\/thno.60427","article-title":"Macrophage-mediated tumor homing of hyaluronic acid nanogels loaded with polypyrrole and anticancer drug for targeted combinational photothermo-chemotherapy","volume":"11","author":"Xiao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0715","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0720","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bioactmat.2022.06.013","article-title":"Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis","volume":"20","author":"Ying","year":"2023","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0725","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1349-7006.2010.01587.x","article-title":"Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer","volume":"101","author":"Matsui","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0730","doi-asserted-by":"crossref","first-page":"eade1444","DOI":"10.1126\/sciadv.ade1444","article-title":"Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer","volume":"9","author":"Melamed","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0735","first-page":"2497","article-title":"Role of extracellular matrix assembly in interstitial transport in solid tumors","volume":"60","author":"Netti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0740","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpb.2011.01.008","article-title":"Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors","volume":"79","author":"Ding","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0745","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11598890-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics","volume":"51","author":"Hasovits","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0750","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biomaterials.2016.06.031","article-title":"Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma","volume":"102","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0755","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/wnan.1451","article-title":"Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle","volume":"9","author":"Colby","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0760","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1021\/acsnano.2c08451","article-title":"Radiolabeled biodistribution of Expansile nanoparticles: intraperitoneal administration results in tumor specific accumulation","volume":"17","author":"Colby","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0765","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.biomaterials.2012.11.038","article-title":"Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0770","first-page":"1951","article-title":"Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery, nanomedicine: nanotechnology","volume":"12","author":"Fu","year":"2016","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0775","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jconrel.2020.11.003","article-title":"Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis","volume":"328","author":"Hargrove","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0780","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/acs.nanolett.2c04486","article-title":"Engineered design of a mesoporous silica nanoparticle-based nanocarrier for efficient mRNA delivery in vivo","volume":"23","author":"Dong","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0785","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2019.1704945","article-title":"Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review","volume":"27","author":"Van de Sande","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-015-0082-8","article-title":"Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model","volume":"13","author":"Noorani","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0795","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/mt.2013.123","article-title":"Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells","volume":"21","author":"Zhu","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0800","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/stem.1051","article-title":"Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model","volume":"30","author":"Yang","year":"2012","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0805","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acs.bioconjchem.7b00237","article-title":"Intraperitoneal administration of neural stem cell-nanoparticle conjugates targets chemotherapy to ovarian tumors","volume":"28","author":"Cao","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0810","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1158\/1541-7786.MCR-08-0146","article-title":"Neural stem cell tropism to glioma: critical role of tumor hypoxia","volume":"6","author":"Zhao","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0815","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.soc.2018.02.003","article-title":"Pharmacokinetics and tissue transport of intraperitoneal chemotherapy","volume":"27","author":"Lagast","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0820","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10717544.2020.1862364","article-title":"Simulating drug penetration during hyperthermic intraperitoneal chemotherapy","volume":"28","author":"L\u00f6ke","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0825","first-page":"3039","article-title":"Transport of molecules in the tumor interstitium: a review","volume":"47","author":"Jain","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0830","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.7b00068","article-title":"Enhancing tumor penetration of nanomedicines","volume":"18","author":"Sun","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0835","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1091\/mbc.e09-07-0591","article-title":"Vascular endothelial growth factor: much more than an angiogenesis factor","volume":"21","author":"Senger","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0840","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.03.012","article-title":"Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles","volume":"277","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0845","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2015.06.009","article-title":"A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis","volume":"212","author":"Sugahara","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0850","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2018.02.052","article-title":"Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo","volume":"166","author":"Wonder","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0855","doi-asserted-by":"crossref","first-page":"21954","DOI":"10.1021\/acsami.2c02552","article-title":"Engineering chemotherapeutic-augmented calcium phosphate nanoparticles for treatment of intraperitoneal disseminated ovarian Cancer","volume":"14","author":"Qiu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0860","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2013.01.026","article-title":"Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia","volume":"167","author":"Li","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0865","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsnano.0c10276","article-title":"Tumor-selective immune-active mild hyperthermia associated with chemotherapy in Colon peritoneal metastasis by Photoactivation of fluorouracil-gold nanoparticle complexes","volume":"15","author":"Mulens-Arias","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0870","article-title":"Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer","volume":"7","author":"Lv","year":"2020","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0875","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/10717544.2019.1660435","article-title":"Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy","volume":"26","author":"Rezaeian","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0880","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000655","article-title":"Electrostatic intraperitoneal aerosol delivery of nanoparticles: proof of concept and preclinical validation","volume":"9","author":"Van de Sande","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0885","first-page":"29024","article-title":"Synergy between intraperitoneal Aerosolization (PIPAC) and Cancer nanomedicine: cisplatin-loaded Polyarginine-hyaluronic acid Nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian Cancer","volume":"12","author":"Shariati","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0890","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejso.2019.03.035","article-title":"Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases","volume":"47","author":"Sugarbaker","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0895","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","article-title":"HIPEC methodology and regimens: the need for an expert consensus","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"2014","key":"10.1016\/j.jconrel.2024.10.011_bb0900","first-page":"519","article-title":"Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review","volume":"164","author":"Tempfer","year":"1946","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107250","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: a systematic review","volume":"49","author":"Taliento","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0910","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2020.10.015","article-title":"Intraperitoneal aerosolized drug delivery: technology, recent developments, and future outlook","volume":"160","author":"Rahimi-Gorji","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0915","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.21.02745","article-title":"Integration of genomic biology into therapeutic strategies of gastric Cancer peritoneal metastasis","volume":"40","author":"Gwee","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0920","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2009.08.034","article-title":"Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice","volume":"383","author":"Mirahmadi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0925","first-page":"2607","article-title":"Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice","volume":"6","author":"Tsai","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0930","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1038\/s41467-018-06730-z","article-title":"Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics","volume":"9","author":"Dogra","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0935","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour \u2014 targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0940","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600740902","article-title":"Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration","volume":"74","author":"Hirano","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0945","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1039\/C7BM00769H","article-title":"The biodistribution, excretion and potential toxicity of different-sized Pd nanosheets in mice following oral and intraperitoneal administration","volume":"5","author":"Chen","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0950","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0309-1651(91)90166-G","article-title":"The effect of size of polystyrene particles on their retention within the rat peritoneal compartment, and on their interaction with rat peritoneal macrophages in vitro","volume":"15","author":"Seymour","year":"1991","journal-title":"Cell Biol. Int. Rep."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0955","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.108.140095","article-title":"Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer","volume":"327","author":"Lu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0960","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2013.11.011","article-title":"The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles","volume":"459","author":"Alinaghi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0939-6411(02)00081-4","article-title":"Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis","volume":"54","author":"Gessner","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0970","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jbm.a.10371","article-title":"Functional groups on polystyrene model nanoparticles: influence on protein adsorption","volume":"65","author":"Gessner","year":"2003","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236373","article-title":"Measurement and visualization of cell membrane surface charge in fixed cultured cells related with cell morphology","volume":"15","author":"Nishino","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0980","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fonc.2020.00401","article-title":"Elucidation of functional roles of sialic acids in Cancer migration","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb0985","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.7150\/thno.16358","article-title":"Targeting negative surface charges of Cancer cells by multifunctional Nanoprobes","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0990","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.11108","article-title":"Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels","volume":"105","author":"Krasnici","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.011_bb0995","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1039\/C2NR31877F","article-title":"Surface chemistry-mediated penetration and gold nanorod thermotherapy in multicellular tumor spheroids","volume":"5","author":"Jin","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1000","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2023.05.027","article-title":"Comprehensive analysis of the influence of physicochemical properties and tumor-associated environments on liposome intratumoral penetration","volume":"359","author":"Lin","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(00)00201-0","article-title":"Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination","volume":"116","author":"Sadzuka","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-\u03b1-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1015","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1020","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/nn300524f","article-title":"Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting","volume":"6","author":"Zhu","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jconrel.2012.03.021","article-title":"Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination","volume":"160","author":"Kumagai","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1035","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/molecules23051190","article-title":"Peritoneal Carcinomatosis targeting with tumor homing peptides","volume":"23","author":"Sim\u00f3n-Gracia","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1040","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jconrel.2023.03.017","article-title":"cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer","volume":"356","author":"Liang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jconrel.2010.02.026","article-title":"Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: therapeutic efficacy and biodistribution in mice","volume":"144","author":"Cirstoiu-Hapca","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1050","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3390\/cancers14102362","article-title":"Using GPCRs as molecular beacons to target ovarian Cancer with nanomedicines","volume":"14","author":"Khetan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/08982100903544185","article-title":"Large anti-HER2\/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer","volume":"20","author":"Sofou","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.bioconjchem.5b00674","article-title":"Production of cisplatin-incorporating Hyaluronan Nanogels via chelating ligand-metal coordination","volume":"27","author":"Ohta","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1065","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10131","article-title":"Layer-by-layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum-based drug resistance therapy in ovarian cancer","volume":"4","author":"Mensah","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.actbio.2021.10.043","article-title":"Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: a comparative study of molecular inhibitors and siRNA therapeutics","volume":"138","author":"Wang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jconrel.2023.03.019","article-title":"Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy","volume":"356","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-020-00965-4","article-title":"In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma","volume":"13","author":"Omstead","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1085","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1021\/acsnano.6b02776","article-title":"The binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors","volume":"10","author":"Miao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1090","first-page":"691","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(85)90174-6","article-title":"Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection","volume":"839","author":"Senior","year":"1985","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes: effect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(88)81372-3","article-title":"Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes","volume":"233","author":"Moghimi","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00280-015-2737-4","article-title":"A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax\u00ae) in patients with peritoneal malignancies","volume":"75","author":"Williamson","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00280-019-03767-9","article-title":"A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity","volume":"83","author":"Cristea","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.10.011_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104151","article-title":"Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases","volume":"82","author":"Ceelen","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067691","article-title":"Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity","volume":"13","author":"Lang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2024.10.011_bb1135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1245\/s10434-022-12723-6","article-title":"A multicenter phase 1 trial evaluating Nanoliposomal irinotecan for heated intraperitoneal chemotherapy combined with Cytoreductive surgery for patients with peritoneal surface disease","volume":"30","author":"Choi","year":"2023","journal-title":"Ann. Surg. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T08:35:43Z","timestamp":1733560543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924006710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":227,"alternative-id":["S0168365924006710"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The journey of nanoparticles in the abdominal cavity: Exploring their in vivo fate and impact factors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}